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CHARACTERISTICS OF BINDING OF INTERLEUKIN-1 TO YT.NCI CELLS

Susan Catherine Speziale, M.S.
Western Michigan University, 1988
lnterleukin-1 (IL-1) demonstrated a concentration dependent,
specific binding to the human, large granular lymphocyte cell line, YT.NCI
w ith a dissociation constant of 0.2 nM. There were approximately 500 IL1 receptors/cell.
IL-1 binding to YT.NCI cells could be inhibited by unlabeled-IL-1 and
the plant lectins, WGA and Con A. Lectin inhibition of IL-1 binding could
be completely abrogated by exposing lectins to specific simple sugars prior
to the addition o f ligand.
Tunicamycin, an inhibitor o f glycosylation, decreased IL-1 binding to
YT cells in a reversible, time- and concentration-dependent manner.
These observations suggest that glycosylation of cell surface proteins
may be im portant for IL-1 receptor orientation, expression, and/or
functional ligand binding. Furthermore, the demonstration that specific
plant lectins effectively compete with iodinated IL-1 fo r IL-1 receptor
occupancy could facilitate the establishment of conditions for successful
isolation and purification o f IL-1 membrane receptors via a ffin ity
chromatography on immobilized lectins.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

ACKNOWLEDGMENTS

I would like to acknowledge my parents, Frank and Mildred Speziale,
whose unfaltering faith in me certainly made this endeavor possible.
I would also like to take this opportunity to say thanks to my friends and
colleagues at work who have continually shown interest in my thesis
project and have cheered me on. I would especially like to acknowledge
my supervisors at The Upjohn Company, Robert J. Smith, Ph.D., fo r
teaching me scientific thoroughness and excellence, and Jefferson W.
Paslay, Ph.D., for encouraging me to expand my horizons and tackle new
challenges.

My advisor, Leonard C. Ginsberg, Ph.D., and committee

members have kept me on target and I'm grateful to them for that.
A special family member, Micheal Kiser, has been at my side for the
past few years. His support has been a godsend.
Finally, I would like to dedicate this thesis to my loving daughter,
Allyson Haag, whose ever-questioning mind always reminds me why I love
science.

Susan C. Speziale

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

INFORMATION TO USERS
This reproduction was made from a copy of a document sent to us for microfilming.
While the most advanced technology has been used to photograph and reproduce
this document, the quality of the reproduction is heavily dependent upon the
quality of the material submitted.
The following explanation of techniques is provided to help clarify markings or
notations which may appear on this reproduction.
1.The sign or “target” for pages apparently lacking from the document
photographed is “Missing Page(s)”. I f it was possible to obtain the missing
page(s) or section, they are spliced into the film along with adjacent pages. This
may have necessitated cutting through an image and duplicating adjacent pages
to assure complete continuity.
2. When an image on the film is obliterated with a round black mark, it is an
indication of either blurred copy because of movement during exposure,
duplicate copy, or copyrighted materials that should not have been filmed. For
blurred pages, a good image o f the page can be found in the adjacent frame. If
copyrighted materials were deleted, a target note will appear listing the pages in
the adjacent frame.
3. When a map, drawing or chart, etc., is part of the material being photographed,
a definite method of “sectioning” the material has been followed. It is
customary to begin filming at the upper left hand comer of a large sheet and to
continue from left to right in equal sections with small overlaps. I f necessary,
sectioning is continued again—beginning below the first row and continuing on
until complete.
4. For illustrations that cannot be satisfactorily reproduced by xerographic
means, photographic prints can be purchased at additional cost and inserted
into your xerographic copy. These prints are available upon request from the
Dissertations Customer Services Department.
5. Some pages in any document may have indistinct print. In all cases the best
available copy has been filmed.

University

Micrdfilms

international
300 N. Zeeb Road
Ann Arbor, Ml 48106

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Order Number 1333168

Characteristics of binding of interleukin-1 to YT.NCI cells
Speziale, Susan Catherine, M.S.
Western Michigan University, 1988

Copyright ©1988 by Speziale, Susan Catherine. All rights reserved.

U MI

300N.ZeebRd.
Ann Arbor, MI 48106

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

PLEASE NOTE:

In all cases this material has been filmed in the best possible way from the available copy.
Problems encountered with this document have been identified here with a check mark •/ .

1.

Glossy photographs or pages_____

2.

Colored illustrations, paper or print______

3.

Photographs with dark background____

4.

Illustrations are poor copy______

5.

Pages with black marks, not original copy

6.

Print shows through as there is text on both sides of page______

7.

Indistinct, broken or small print on several pages

8.

Print exceeds margin requirements_____

9.

Tightly bound copy with print lost in spine______

^
</

10.

Computer printout pages with indistinct print_____

11.

Page(s)__________ lacking when material received, and not available from school or
author.

12.

Page(s)__________ seem to be missing in numbering only as text follows.

13.

Two pages numbered

14.

Curling and wrinkled pages_____

15.

Dissertation contains pages with print at a slant, filmed as received________

16.

Other_______________________________________________________________

. Text follows.

TJMI
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Copyright by
Susan Catherine Speziale
1988

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

TABLE OF CONTENTS

ACKNOWLEDGMENTS

.......................................................

ii

LIST OF TABLES ........................................

v

LIST OF FIGURES ................................................................................

vi

INTRODUCTION

1

...................

MATERIALS AND METHODS
M a te ria ls

...................................

8

.................................................

8

YT.NCI C ells.............................................................

8

Recombinant Protein.....................

8

Preparation of lodinated L igand..............................................

8

Lectins and Sugars...................................

9

M ethods......................................................

.

10

Binding Assay................................................................... 10
Fluorescence..................................................................... 11
Calculations........................

11

RESULTS .............................................................................
Binding of l25|-rhulL-10 to YT Cells

..............................

13
13

Scatchard Analysis..................................................................... 13
Inhibition of Binding o f l25|-rhulL-10 to YT Cells by
Unlabeled rhulL-10 ................................................................... 16
Effect of Lectins on Binding of i25|-rhulL-10 to YT
Cells............................................................................................ 16

til

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Table of Contents-Continued

Inhibition o f IL-1 Binding by rhulL-18 or
Wheat Germ A gglutinin ........................................................

18

Effect of Sugar Moieties on Inhibition of
IL-1 Binding by Lectins..........................................

18

Effect of Tunicamycin Treatment on Binding of
i25|-rhulL-10 to YT C ells...........................................

22

Kinetics o f Tunicamycin Effect on Binding of
l25|-rhulL-l0 to YT C ells..............................................

25

Flow Cytometric Analysis o f WGA-FITC Binding
Following Tunicamycin Treatment of YT Cells.................... —

25

Binding of i25|-rhulL-10 to YT Cells Following
Removal o f Tunicamycin.............................................................

28

DISCUSSION

....................................................................................... 32

CONCLUSION

....................................................................................... 38

BIBLIOGRAPHY

.............................

39

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

LIST OF TABLES

1.

Carbohydrate Binding Properties of Lectins................................

6

2.

Effect o f Lectins on Binding of i25|-rhulL-1B to
YT Cells
.............................

19

3.

Effectof Lectins on Binding o f i25|-rhulL-lB to
.............................................................
YT Cells

20

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

LIST OF FIGURES

1. Binding of i25|-rhulL-10 to YT Cells.........................

14

2. Binding o f i25|-rhulL-1B to YT Cells: Scatchard
Analysis...........................................................................

15

3. Inhibition of Binding o f i25|-rhulL-1 Bto YT Cells by
Unlabeled-rhulL-1B...........................................................

17

4. Inhibition of IL-1 Binding by rhulL-1 Bor
Wheat Germ A gglutinin.............................................................. 21
5. Effect of Sugar Moieties on Inhibition of
IL-1 Binding by Lectins................................................................. 23
6. Effect o f Sugar Moieties on Inhibition of
IL-1 Binding by Lectins............................................

24

7.

Effect o f Tunicamycin Treatment on Binding of
i25|-rhulL-1B to YT C ells.............................................................. 26

8.

Kinetics o f Tunicamycin Effect on Binding of
125|-rhulL-l8 to YT C ells.............................................................. 27

9.

Flow Cytometric Analysis of WGA-FITC Binding Following
Tunicamycin Treatment of YT C ells............................................ 29

10. Binding of i25|-rhulL-1 Bto YT Cells Following
Removal o f Tunicamycin.............................................................. 31

vi

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

INTRODUCTION

Interleukin-1 (IL-1) is a cytokine which is produced by a large variety
o f mammalian cell types, in c lu d in g m onocytes, m acrophages,
keratinocytes, astrocytes and endothelial cells. The first activity ascribed
to IL-1 was the ability o f culture supernatants from human peripheral
blood adherent leukocytes to stim ulate p ro life ra tio n o f m urine
thymocytes, but not immunocompetent peripheral lymphocytes (Gery,
Gershon & Waksman, 1972). Gery et al. (1972) also demonstrated that IL1 synergized with the mitogens, concanavalin A and phytohemagglutinin
to augment murine thymocyte and splenic T cell proliferation. This initial
activity labeled IL-1 as a lymphocyte activating factor (LAF) and remains a
standard fo r ascribing IL-1-like activities to various molecules. Since then,
IL-1 has been attributed w ith other biological functions and jn vitro
activities, such as:

induction o f acute phase protein production by

hepatocytes; stimulation o f prostaglandins, collagenase and plasminogen
activator from chondrocytes, osteoclasts and fibroblasts d u rin g
inflammation, tissue repair and wound healing; stimulation of immune
responsiveness by inducing lymphokine secretion; chemotactic properties;
and fever production. Several factors are now known to be biologically,
biochemically and structurally sim ilar to IL-1, including epidermal
thymocyte activating fa cto r (ETAF), B cell activating factor (BAF),
endogenous pyrogen (EP) and ca ta b o lin (O ppenheim , Kovacs,
■ Matsushima & Durum, 1986).

Mizel, Kilian, Lewis, Paganelli and

Chizzonite (1987) demonstrated that IL-1 could stimulate the production

1
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of collagenase and prostaglandins by synovial cells from rheumatoid
arthritic patients. Russell, McGuire, Meats, Ebsworth and Beresford (1981)
showed that rheumatoid synovium could produce factors which stimulate
chondrocytes to degrade their own matrix, resulting in bone loss.

In

addition, IL-1 has been shown to induce fibroblast proliferation (Schmidt,
Mizel, Cohen & Green, 1982), and its production by infiltrating monocytes
may contribute to the fibrosis and tissue destruction seen in chronic
inflammatory disease. Therefore, IL-1 is thought to be a principle
m ediator in many normal, as well as pathological, immune and
immunoinflammatory processes.

A large research effort is on-going to

find IL-1 antagonists which may be used as therapeutic agents, particularly
in inflammatory diseases.
Two polypeptides have been identified which share IL-1 biological
activities, IL-1 alpha and IL-1 beta. These polypeptides have molecular
weights of 15-20,000 daltons and have distinct amino acid sequences and
isoelectric points (Oppenheim et al., 1986). In spite of the growing body
of knowledge on IL-1 structure and function, little is known about
intracellular signal transduction mechanisms or regulation of IL-1.
Apparently both IL-1a and IL-1 B exert their myriad biological effects
by interaction with the same receptor (Dower et al., 1986; Kilian et al.,
1986; Matsushima, Akahoshi, Yamada, Furutani & Oppenheim, 1986a).
Why nature selected tw o distinct molecules to carry out similar functions is
a mystery that remains to be resolved.
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Characteristics o f the IL-1 receptor and binding of its ligand are
beginning to be elucidated. Molecular weight o f the integral membrane
protein IL-1 receptor is estimated at 60-100,000 daltons (Dower and Urdal,
1987; Matsushima et al., 1986a), but purification and primary structure
have not yet been described.

IL-1 receptors have been enumerated on

several cell types (Dower and Urdal, 1987) and, compared to other
hormone receptors, IL-1 receptor densities are quite small.

Mouse

thymocytes, spleen cells and lymph node cells reportedly have fewer than
10 IL-1 receptors per cell. Human peripheral blood mononuclear cells have
less than 30 IL-1 receptors/cell, human T cells have about 100/cell, while
human gingival and dermal fibroblasts have 2000-5000 IL-1 cell surface
receptors (Dower and Urdal, 1987). A variety of in vitro cell lines .have
been analyzed for IL-1 receptors.

A subclone of the murine T cell

lymphoma EL4 cell line was found to have approximately 10,000 IL-1
receptors/cell, the highest density of IL-1 cell surface receptors reported to
date. Investigators screening various human cell lines have found few
with relatively high IL-1 receptor densities (Dower and Urdal, 1987).
Matsushima, Yodoi,Tagaya and Oppenheim (1986b) recently described an
IL-1 receptor density o f 7000 receptors/cell on YT cells, a cell line derived
from a 15 year old boy with acute lymphoblastic lymphoma and thymoma
(Yodoi et al., 1985). YT cells grow continuously in typical suspension
culture. This human cell line expressed surface antigens similar to those
seen on large granular lymphocytes, known as natural killer cells, such as
interleukin-2, Fc receptors fo r IgG and an antigen found on a subset of
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natural killer cells, HNK-1. YT cells also demonstrated killing against
several human target cell lines, typical of natural killer-like activity (Yodoi
etal., 1985). YT cells were selected for the studies planned in this research
project.
The purpose of this master's thesis is to explore IL-1 binding, utilizing
tools, such as lectins and an antibiotic inhibitor of glycosylation, which
may shed light on the primary structure o f the IL-1 receptor.

I w ill

attempt to study aspects o f IL-1 receptor binding that relate to receptor
recognition structures through the use o f lectins. Lectins are proteins that
have become useful tools fo r exploring the surface characteristics o f
numerous mammalian cells and tissues. These proteins were first known
as erythrocyte agglutinins and, later, as lectins, because o f their ability to
distinguish between human blood group antigens. They were more
recently redefined (Goldstein, Hughes, Monsigny, Osawa & Sharon, 1980)
as proteins that recognize specific sequences of sugar residues that can
agglutinate cells or precipitate glytoconjugates, but are not antibodies.
Implicit in this definition is that a lectin must have at least 2 sugar-binding
sites to provide the capability to cross-link glycoproteins or other
glycoconjugates that would result in agglutination or precipitation.
Several investigators (i.e., Cuatrecasas, 1973; Monsigny, Roche, Sene,
Maget-Dana & Delmotte, 1980) have demonstrated biphasic or more
complex binding of lectins to intact cells.

Experiments conducted by

Monsigny et al. (1980) suggested that sugar-lectin interactions depend on
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the structure and density o f sugar residues available for binding, as well as
on charge effects.
Lectin specificity is defined primarily by the free sugar or sugars that
will inhibit the agglutination or precipitation that the lectin induces.
However, as Monsigny et al. (1980) and others (Hedo, 1984) have
indicated, there are instances where a free, simple sugar will not inhibit
lectin activities, but the same sugar moiety found within a glycoconjugate
may bind lectin. Table 1 contains a list of the lectins used in experiments
reported here and their various sugar specificities.
Since sugar-lectin binding is reversible and can be inhibited by simple
sugars, lectins are frequently derivatized, immobilized on solid matrices
and thereby used to isolate and purify membrane receptors via a type of
affinity chromatography. This technique has been used successfully to
isolate a number of receptors, including receptors for acetylcholine,
epidermal growth factor, immunoglobulin E and insulin (Hedo, 1984), and
thereby helped to establish th a t these membrane receptors were
glycoproteins. The process of selecting a lectin for this purpose involves
screening a variety of lectins with different sugar specificities in a binding
assay, looking for the ability o f free lectin to antagonize binding of the
specific ligand to the receptor in question. Part of the purpose of this
research is to test a panel o f 9 lectins in an intact-cell, IL-1 receptor binding
protocol.
In order to further explore the importance of glycoprotein structures
in IL-1 binding, the antibiotic tunicamycin was incorporated into cell
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Table 1
Carbohydrate Binding Properties of Lectins

Lectin

Plant Source

Sugar Specificity

Concanavalin A
(Con A)

Canavalia ensiformis

a-D-mannose
ct-D-glucose

Lentile Culinaris hemagglutinin
(LCH)

Lens culinaris

a-D-mannose
a-D-glucose

Mycoplasma gallisepticum
agglutinin
(MGA)

Mvcoolasma oalliseDticum

glycophorin
(sialyl glycoprotein)

Phytohemagglutinin
(PHA)

Phaseolus vulaaris
(red kideny bean)

N-acetyl-D-galactosamine

Pokeweed mitogen
(PWM)

Phytolacca americana

N-acetyl-B-D-galactosamine

Soybean agglutinin
(SBA)

Glycine max

N-acetyl-D-galactosamine

Ulex europaeus agglutinin
(UEA)

Ulex eurooaeus
(gorse, UEA 1)

a-L-fucose

Wheat germ agglutinin
(WGA)

Triticum vulqaris

N-acetyl-B-D-glucosamine

Wisteria floribunda agglutinin
(WFA)

Wisteria floribunda

N-acetyl-D-galactosamine

7

growth media to block protein glycosylation. Tunicamycin inhibits lipid
carrier-dependent protein glycosylation by blocking a specific transferase
which catalyzes the transfer o f N-acetylglucosamine to dolichyl
phosphate, the first step in glycosylation o f nascent polypeptides (Duksin
& Mahoney, 1982). The transfer o f oligosaccharide to a newly synthesized
protein occurs in the lumen o f the endoplasmic reticulum (Keller, 1987).
The new glycoprotein can then be transported to o the r ce llula r
organelles, such as the golgi. Carbohydrate structures on glycoproteins
are modified in the golgi, resulting in proteins containing either complex
oligosaccharides or simpler ones that are high in mannose. Inhibition of
glycosylation by tunicamycin is accompanied by minimal effect on protein
synthesis, less than 10% o f control, as reported by Chatterjee, Kwiterovich
and Sekerke (1979) and Ronnett and Lane (1981). My studies will look at
tunicamycin's effect on IL-1 binding in a typical binding assay using
iodinated ligand, and on lectin binding via flo w cytometry using
fluorescently-labeled lectin.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

MATERIALS AND METHODS
Materials

YT.NCI Cells
Human YT.NCI cells (YT, obtained from K. Matsushima, NCI,
Frederick, MD) were maintained in suspension culture at 37° C, 5% C02, in
RPMI-1640 (GIBCO, Grand Island, NY) containing 10% fetal calf serum
(heat-inactivated, Hyclone, Logan, UT), 2 mM L-glutam ine (MA
Bioproducts, Walkersville, MD), and 50 yg/ml gentamicin (GIBCO).
Tunicamycin (Sigma, St. Louis, MO) was dissolved in culture medium.
Cell viability was determined by trypan blue dye exclusion.
Recombinant Protein
Recombinant human IL-1 B (rhulL-1 B; Batch 12/86) was cloned,
expressed in E. coli. isolated, purified, and iodinated at The Upjohn
Company, Kalamazoo, Ml. Grade I rhulL-10 (100% pure) was used for
iodination, while Grade III (95-99% pure) was used as cold IL-1 fo r
competition studies and in demonstration of non-specific binding (NSB).

Preparation of Iodinated Ligand
Mono-iodo-i25|.Bolton Hunter reagent (Amersham, A rlington
Heights, IL) was coupled to rhulL-18 (2 x 107 U/mg) according to the
published method (Bolton & Hunter, 1973). Iodination o f rhulL-1 B was

8
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achieved without loss in bio-activity, as measured by a modification of the
interleukin-1/interleukin-2 T-cell assay (Gillis & Mizel, 1981).

Specific

activity o f i25|-rhulL-1 B ranged from 1313-2611 Ci/mmole. Sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) of i25|-rhulL-18
consistently revealed a single peak of iodinated protein at 20,000 daltons.
Lectins and Sugars
Concanavalin A (Con A) was purchased from Miles Scientific
(Naperville, IL). Phytohemagglutinin (PHA, red kidney bean) was ob
tained from Burroughs Wellcome (HA 17, Dartford, England). The lectins,
lentil hemagglutinin (LCH). Mycoplasma qallisepticum agglutinin (MGA),
pokeweed mitogen (PWM), soybean agglutinin (SBA) Ulex europaeus
agglutinin (UEA), wheat germ agglutinin (WGA) and Wisteria floribunda
agglutinin (WFA) were purchased from the Sigma Chemical Co. (St. Louis,
MO).

N-acetyl-D-glucosamine (NAGIu), N-acetyl-D-galactosamine

(NAGal), a-D-mannose (MAN), a-methyl-D-glucoside (MG),

a-D-fucose

(FUC), and N-acetylneuraminic acid (NAN) were purchased from Sigma.
Lectins and sugars were dissolved in receptor binding media at the
concentrations indicated in RESULTS.
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Methods
Binding Assay
YT cells were harvested by centrifugation at 10°C, washed once in
cold receptor binding media, consisting of RPMI-1640,1 mg/ml BSA (Cohn
Fraction V, Miles, Elkhart, IN), 20 mM Hepes (Sigma, St. Louis, MO), and
0.1% sodium azide at pH 7.2, re-suspended at 2 x 107/ml in binding media
and delivered at 100 pl/tube for assay. Replicate samples containing YT
cells and iodinated-rhulL-1 B (50 pl/tube; diluted in binding media) were
vortexed and incubated in Skatron macrowell tubes (Skatron, Sterling,
VA) in the presence or absence o f unlabeled-rhulL-1 B at varying
concentrations for 60 minutes at room temperature. Tubes were shaken
on an orbital shaker during the incubation.

Total reaction mixture

volume was 0.2 ml/tube. Cell bound ligand was measured by harvesting
the cells (Skatron cell harvester) onto receptor binding paper (Skatron,
glass fiber filter) which had been soaked in cold milk (5% Carnation
instant non-fat dry milk in PBS with 0.1% sodium azide) for 60 minutes.
Unbound ligand was removed by washing the cells on the filter pad w ith 4
ml cold Tween 20 (0.05% Tween 20 in PBS). Filters were counted in a
Packard A800C Gamma Counter. Aliquots of iodinated IL-1 (50 pi) were
used to measure "total added" i25|-rhulL-1 B- Controls were included in
each experiment to: (1) determine maximum binding in the absence of
unlabeled ligand, (2) determine non-specific binding in the presence of
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excess unlabeled ligand, and (3) generate a standard com petitive
inhibition curve using unlabeled free ligand.
Fluorescence
YT cells were washed, re-suspended (1 x 107/ml) in fluorescence (FL)
media which consisted o f Hanks' Balanced Salt Solution, containing 2%
fetal calf serum, 25 mM Hepes and .02% sodium azide, and delivered to a
Costar U-bottom 96-well microtiter plate (1 x 106/100 ul/well). The cells
were then incubated w ith WGA labeled with fluorescein isothiocyanate
(WGA-FITC; Polysciences, Inc., W arrington, PA) at 0.1 mg/ml fo r 60
minutes at 4°C, washed in FL media twice, washed in PBS once and fixed in
1% paraformaldehyde. Fluorescence was measured on an Epics 753 flow
cytometer, using an argon ion laser emitting 488 nM wavelength light.
For each sample 20,000 cells were examined. Dead cells were excluded via
appropriate scatter window gating. Fluorescent signals were displayed
via logarithmic amplification.
Calculations
Percent of control binding was calculated, as follows:
cpmCONTROL-cpmUNKNOWN x 100 = % of Control Binding
cpmCONTROL

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Scatchard, an interactive computer program fo r calculating receptor
binding parameter estimates in which both linear and non-linear
regression analyses are performed, was used to estimate dissociation
constants and receptors/cell (Berzins & Ruppel, 1987). RBPAS, software
included in the Scatchard package, was used to calculate ICso's. Student's
t-test was used for comparisons of mean values. Estimates o f error were
expressed as standard error o f the mean (SEM).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

RESULTS
Binding of i25|.rhulL-1 Bto YT Cells

YT cells (2 x 107/ml) were incubated with various amounts of 125|rhulL-18 (specific activity 2210 Ci/mmole) in 0.2 ml binding media for 60
minutes at room temperature. As shown in Figure 1, the large granular
lymphocyte-like cell line, YT, specifically bound i25|-rhulL-18- Binding
increased with increased amounts of radiolabel up to the saturation point,
approximately 20 fmole/tube. Non-specific binding was determined by
the addition of 44 pmole unlabeled rhulL-1 B- Data represent the mean of
duplicate samples from a single representative experiment.
Scatchard Analysis

YT cells (2 x 107/ml) were incubated with varying amounts of 12S|rhulL-18 (0.24 pmole/tube at the highest dilution; specific activity 2611
Ci/mmole) in 0.2 ml binding media for 60 minutes at room temperature.
Non-specific binding was determined by the addition o f 29 pmole
unlabeled-rhulL-1 B- Scatchard analysis revealed th a t YT cells have
approximately 500 IL-1 receptors/cell (see Figure 2). The dissociation
constant for i25|-rhulL-18 binding to YT cells was approximately 0.2 nM,
the concentration of IL-1 required to saturate 1/2 the available binding
sites. Results are from duplicate samples from a single representative
experiment.

13
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Inhibition of Binding of i2S|-rhulL-10 to YT Cells by Unlabeled rhulL-10

As shown in Figure 3, YT cells (2 x 107/ml) were incubated with a
saturating concentration (11-28 fmole/tube; specific activities 1641-1761
Ci/mmole) o f i25|-rhulL-10 and varying concentrations of unlabeled-rhulL10 (0.003-3 nM) in 0.2 ml binding media fo r 60 minutes at room
temperature. Data represent the mean ± SEM from 4-5 experiments in
which duplicate samples were run. This titration of rhulL-10 against a
fixed am ount o f 125-|-rhuIL-1 0 enabled d e te rm in a tio n o f the
concentration o f IL-1 B which would reduce maximum binding o f
iodinated-IL-10to YT cells by 50% (IC5 0 ). ThelCsowas3 ng/ml rhulL-10.
Effect of Lectins on Binding of i25|-rhulL-10 to YT Cells

YT cells (2 x 107/ml) were incubated with a saturating concentration
o f i25|-rhulL-10 (10-35 fmole; specific activities 1313-2210 Ci/mmole) and
various concentrations (200, 40 or 8 ng/ml) of lectin in 0.2 ml binding
media for 60 minutes at room temperature. Non-specific background
binding (NSB) was determined by incubation of YT cells with 500 ng/ml
unlabeled-rhulL-10. Data represent the mean ± SEM of 1-3 experiments.
As seen in Table 2, WGA and Con A demonstrated significant inhibition of
binding at 200 ug/ml, PWM exhibited some inhibition, while PHA had no
effect on binding. In subsequent experiments several other lectins were
tested. The data shown in Table 3 indicate that SBA, LCH, MGA, UEA and
WFA did not inhibit binding of 125|-rhulL-10 to YT cells. The lentil lectin,
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LCH, and the Mycoplasma lectin, MGA, produced some enhancement of
binding at 40-200 ug/ml.
Inhibition of IL-1 Binding by rhulL-18 or Wheat Germ Agglutinin

Results are shown in Figure 4 in which YT cells (2 x 107/ml) were
incubated in the presence of rhulL-18 (0.1-500 ng/ml) or WGA (7.8-1000
ug/ml) and a saturating concentration of i25|-rhulL-l8 (20 fmole/tube;
specific activity 1593 Ci/mmole) in 0.2 ml binding media for 60 minutes at
room temperature. Data represent the mean ± SEM of 2 experiments in
which duplicate samples were assayed. As illustrated in the plot in Figure
4, there was an almost 30,000-fold difference between rhulL-18 and WGA
in terms of ability to antagonize i25|-rhulL-18 binding to YT cells. The IC5 0
for rhulL-18 was 1.4 ± 0.4 ng/ml, while the IC5 0 for WGA was 31 ± 10.5
ug/ml.
Effect of Sugar Moieties on Inhibition of IL-1 Binding by Lectins

Various concentrations o f lectin (250, 50, 10 ug/ml) were pre
incubated with excess sugar (2.5mg/ml; 0.01-.02 M) for 30 minutes at
room temperature prior to addition o f YT cells (2 x 107/ml), 1 25|-rhulL-18
(10-35 fmole/tube; specific activities 1313-2210 Ci/mmole) and incubation
60 minutes at room temperature. Total volume was 0.2 ml in binding
media.

Data represent the mean of 2-3 experiments in which duplicate

samples were run. As shown in Figures 5 & 6, sugars alone did not cause
inhibition or significant enhancement of IL-1 binding to YT cells.

In
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Table 2

Effect of Lectins on Binding of i25|-rulL-1 8 to YT Cells

Sample

Control

Concentration
pM

1251-rulL-lBBounda
cpm

%
Control

2173 ±160

100

—

WGA

5.6
1.1
0.2

1080±174b
1728 ±253
2320 ±187

50
80
107

PHA

3.1
1.6
0.3

2734 ±171
2195 ±164
2080 ±148

109
101
96

PWM

6.3
1.3
0.3

1495 ±116
1809 ±189
1933 ±273

69
83
89

Con A

2.0
0.4
0.1

1339±178b
2186 ±280
2146 ±223

62
101
99

NSBc

—

136 ±

13b

6

a YT cells (2x107/ml) were incubated with a saturating concentration of 125|rulL-10 (35 fm ole; specific activity 1313 Ci/mmole) and various
concentrations (200,40 or 8 ug/ml) o f lectin in 0.2 ml binding media for 60
minutes at room temperature. Data represent the mean ± SEM of 2-3
experiments.
b p <.0.01, as compared to Control binding
c NSB = non-specific binding
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Table 3
Effect of Lectins on Binding of i25|-rulL-1 Bto YT Cells

Sample
Control

Concentration
pM

1251-rulL-l B Bounda
cpm

%
Control

2508 ± 4

100

—

SBA

1.8
0.4
0.1

2569 ±37
2506 ±18
2446 ±14

102
100
98

LCH

4.1
0.8
0.2

2837±65b
2714±2b
2451 ±51

113
108
98

MGA

200c
40
8

2910±58b
2582 ±56
2452 ±20

116
103
98

UEA

1.2
0.2
0.1

2443 ± 53
2484 ±56
2260 ±110

97
99
90

WFA

2.9
0.6
0.1

2577 ±99
2415 ±25
2388 ± 88

103
96
95

116 ± 4

5

NSBd

-

a YT cells (2x107/ml) were incubated with a saturating concentration of 125IrulL-13 (10 fm ole; specific activity 2210 Ci/mmole) and various
concentrations (200,40 or 8 ug/ml) of lectin in 0.2 ml binding media for 60
minutes at room temperature. Data represent the mean ± SEM of
duplicate samples from a single representative experiment.
b p <0.01, as compared to Control binding
c Concentration expressed in ug/ml; molecular weight undetermined
d NSB = non-specific binding
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addition, lower concentrations of sugars (0.1-2 mg/ml) had no effect on
binding (data not shown).

As seen in Figure 5, the glucoside MG

effectively prevented Con A inhibition of IL-1 binding, while other sugars
incubated with Con A had no effect. Also shown in Figure 5, only NAGIu
significantly abrogated WGA inhibition o f IL-1 binding; other sugars were
ineffective.

PHA had a slight enhancing effect on IL-1 binding, as seen

previously (Table 2), and the addition of NAGIu did not appreciably alter
that effect (Figure 5). However, NAGIu did abolish the inhibition of IL-1
binding caused by PWM (Figure 5).

Sugars other than NAGIu were not

tested with the lectins PHA or PWM. As shown in Figure 6 none o f the
sugars tested had any effect on binding, alone or in combination with the
lectins, LCH, MGA, SBA, UEA, or WFA.
Effect of Tunicamycin Treatment on Binding
of i25|-rhulL-18 to YT Cells
YT cells (4 x 105/ml) were incubated with various concentrations of
tunicamycin (0.01-20 ug/ml) in culture media for 24 hours at 37°C. The
cells were washed once and re-suspended in binding media (2 x 107/ml),
then incubated with a saturating concentration o f i25|-rhulL-1 S (10
fmole/tube; specific activity 2210 Ci/mmole) in 0.2 ml binding media for 60
minutes at room temperature. Data represent the mean ± SEM of 2
experiments in which quadruplicate samples were tested. There was no
significant change in cell viability which ranged from 88% for untreated
cells to 82-97% fo r tunicamycin treatment.

As shown in Figure 7,
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treatment of YT cells with tunicamycin caused a dose-related inhibition of
binding of i25|-rhulL-10. YT treatment with 5 ug/ml tunicamycin over 24
hours caused a 61% decrease in binding o f i25|-rhulL-10, while 10-20
ug/ml tunicamycin further inhibited binding by 76% during that same
period o f incubation.
Kinetics of Tunicamycin Effect on Binding
of l25|-rhulL-1 0 to YT Cells

YT cells (2-4 x 105/ml) were incubated with 2.5 ug/ml tunicamycin in
culture media for various lengths of time (0-48 hours) at 37°C. The cells
were washed once, re-suspended in binding media (2 x 107/ml), and then
incubated w ith a saturating concentration o f i25|-rhulL-10 (8-10
fmole/tube; specific activity 2210 Ci/mmole) in 0.2 ml binding media for 60
minutes at room temperature. Data represent the mean of quadruplicate
samples from a single experiment. Tunicamycin treatment did not alter
YT cell viability, until it had been present fo r 48 hours, at which time the
cells were only 50% viable.

As seen in Figure 8, tunicamycin treatment

affected a time-related inhibition of i25|-rhulL-10 binding to YT cells with
maximum inhibition occurring at 24 hours.
Flow Cytometric Analysis of WGA-FITC Binding Following
Tunicamycin Treatment of YT Cells

YT cells (3 x 105/ml) were incubated with 5 ug/ml tunicamycin in
culture media for 24 hours at 37°C. The cells were washed twice, re
suspended in FL media (1 x 107/ml) and incubated with WGA-FITC (0.1
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mg/ml) for 60 minutes at 4°C. Fluorescence of fixed cells was measured via
flo w cytometry. Data are representative of a single experiment in which
fluorescence o f 20,000 individual cells per sample were evaluated.
Background autofluorescence was negligible (2-2.3%). Data is expressed
as relative cell number versus relative fluorescence intensity (Figure 9).
Peak fluorescence of WGA-FITC bound to YT cells occurred at channel
#171 for untreated cells (mean channel = 177.9 ± 22.3), while peak
fluorescence for tunicamycin treated cells was at channel #157 (mean
channel= 164.9 ± 24.8).

This shift in mean fluorescence channels,

however, was not statistically significant. The percentage o f fluorescent
cells was 99.3% for untreated cells and 99.5% fortunicamycin-treated YT
cells.
Binding of i25|-rhulL-1 Bto YT Cells Following
Removal of Tunicamycin

YT cells (4 x 105/ml) were incubated with 5 ug/ml tunicamycin in
culture media for 24 hours at 37°C, then washed twice, re-suspended in
sterile culture media (2 x 105/ml) and incubated at 37°C for various periods
of time (0-72 hours). The cells were then washed once, re-suspended in
binding media (2 x 107/ml), and incubated with a saturating concentration
of i25|-rhulL-1 B (9-12 fmole/tube; specific activity 2611 Ci/mmole) in 0.2 ml
binding media for 60 minutes at room temperature.

Data represent the

mean of duplicate samples from a single experiment.

V iability o f

untreated YT cells averaged 85% over th e e ntire le n g th o f th e
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experiment. Viability of tunicamycin treated cells was 82% following the
initial 24 hour incubation. After removal o f tunicamycin and re-culturing,
cell viability of tunicamycin-treated cells was between 60-63% for the next
6-72 hours, during which cell division occurred at a much slower rate than
normal. Recovery of IL-1 binding was not seen until 48 hours following
removal o f tunicamycin, as shown in Figure 10.

A large increase in

binding o f i25|-rhulL-10to YT cells (170% Control) occurred at 72 hours.
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DISCUSSION

lodinated-IL-1 Bdisplayed a high degree of specific binding to intact
YT cells. Binding data were generated under equilibrium conditions,
previously determined (Matsushima et al., 1986a), and included the
presence o f sodium azide which w ould prevent receptor-ligand
internalization or degradation. Binding appeared to be saturable, as well
as dependent on ligand concentration.

The kinetics of IL-1 binding

appear to be commensurate with that o f IL-1 biological responses (Dower
et al., 1985, Paslay, 1987). Therefore, these data are consistent w ith the
presence of specific IL-1 receptors on YT cells. In addition, scatchard plots
were linear, suggesting a simple unimolecular interaction of ligand w ith a
single class o f binding sites. The dissociation constant for this binding was
similar to Kd's reported by other investigators (Matsushima et al., 1986a;
Matsushima et al., 1986b; Dower et al., 1985).

However, the number of

IL-1 receptors reported by Matsushima et al. (1986b) was considerably
higher than that observed here, although these cells were obtained from
Matsushima’s cultures at the National Cancer Institute. It is possible that
YT cells grown in Kalamazoo have lost the ability to express as high a
proportion o f IL-1 receptors as they once had.
Unlabeled recombinant IL-1B was capable o f competing, in a
concentration-dependent fashion, with iodinated IL-18 for binding to YT
cells. The IC5 0 for this inhibition was consistent with the Kd revealed by
scatchard
analysis, suggesting stoichiometric interaction.
u
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The plant lectins WGA and Con A had a statisticly significant
inhibitory effect on IL-1 binding to intact YT cells. PWM also inhibited IL-1
binding, but in a less consistent manner than WGA or Con A. Fairly large
quantities o f lectin (40-200 ug/ml) were required to demonstrate
inhibition of IL-1 binding.

Since there are so few IL-1 receptors on YT

cells, the data suggests that these lectins may be binding to other sites on
YT cells.

In fact other investigators have reported 39-46 million binding

sites for WGA on baby hamster kidney fibroblasts (Monsigny et al., 1980)
and 300 million binding sites for WGA and Con A on isolated rat fat cells
with an apparent association constant o f 80 nM (Cuatrecasas, 1973).
Saturation of that many sites would require at least 6-16 ug/ml of WGA or
Con A.

These lectins have long been used to agglutinate and/or

m itogenically stimulate lymphocytes in a w ide variety o f jn vitro
immunological protocols with optimal concentrations in the ug/ml range
(Gillis & Mizel, 1981; Lloyd & Panush, 1977; Middleton & Bullock, 1984).
Data with fluorescein-labeled WGA' show a large number of YT cells that
are very brightly fluorescent, suggesting that YT cells possess large
numbers of lectin binding sites. Scatchard analyses performed by
Cuatrecasas (1973) and Monsigny et al. (1980) demonstrated that lectin
binding is quite complex with multiple binding sites of varying affinities
involved. These authors quoted general affinity constants, but indicated
that discrete binding constants fo r each site were impossible to assign.
Therefore, estimating the amount o f lectin required to inhibit IL-1 binding
is difficult. The data shown here, particularly fo r WGA, would suggest
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that inhibition o f IL-1 binding can be realized if large quantities of lectin
are added, perhaps 10-100 times more than estimates of lectin binding
sites would suggest. Other investigators (Carpenter & Cohen, 1977;
Costlow & Gallagher, 1977) reported results similar to these in which ug
quantities o f lectin are required to inhibit binding. Finally, sugars present
in the binding media could impede lectin binding and, therefore, increase
the amount o f lectin required to inhibit IL-1 binding.

Internalization o f

lectin or cell surface receptors should not be an issue here, because all
binding experiments were performed in the presence of sodium azide, an
anti-metabolite.
Certain sugars act as "haptenic inhibitors" (Hedo, 1984) of lectin
interactions w ith cells. This sugar specificity was apparent in the data
described here, in which WGA and Con A inhibition of IL-1 binding was
completely abrogated by previous exposure of WGA with NAGIu or Con A
with MG, while exposure of these lectins to irrelevant sugars or sugars
alone had no significant effect. These results suggest that WGA and Con
A can effectively compete with IL-1 for specific moieties on or close to the
IL-1 receptor.
Although lectin binding to glycoconjugates is reversible (Hedo,
1984), sugars had to be pre-incubated with lectin in order to prevent
lectin-inhibition of IL-1 binding in these experiments.

Perhaps, a higher

temperature, longer incubation time, or higher sugar concentration
would have enabled sugars to effect reversal of the lectin-inhibition, if
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sugar and lectin were added simultaneously with IL-1. However, those
experiments were not attempted here.
Lentil lectin (LCH), which shares the same sugar specificities as Con A,
did not inhibit IL-1 binding in these studies. Although Hedo, Harrison and
Roth (1981) have reported that Con A and LCH are equally capable of
inhibiting insulin binding to placental receptors, other investigators have
observed th a t Con A is much more effective than LCH in blocking
epidermal growth factor binding (Carpenter 8t Cohen, 1977) or prolactin
binding (Costlow & Gallagher, 1977) to human fibroblasts. Con A, which is
tetravalent, may be able to cross-link receptors more effectively than LCH,
which is divalent, and thereby inhibit IL-1 binding.

However, Carpenter

and Cohen (1977) suggest that the differences may also result from other
aspects of lectin binding, such as the 100-fold lower association constant
of LCH for sugar residues, as compared to Con A.
The lectin and sugar specificity demonstrated in these studies
suggests that N-acetyl-glucosamine'and/or glucosides may be found on or
in close proximity to the IL-1 receptor.

These data, along w ith the

inhibitory effects o f tunicamycin treatment, imply that the IL-1 receptor is
glycosylated. Since sialic acid- and fucose-specific lectins did not inhibit IL1 binding, this could indicate that the carbohydrate moieties on the IL-1
receptor protein may not be complex sugars or that processing in the
golgi does not result in a highly modified carbohydrate structure fo r the
IL-1 membrane receptor.
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The lectin specificity observed in these experiments may aid in the
selection o f a lectin for isolation and purification of the IL-1 receptor by
lectin chromatography. It should be noted that inhibition o f binding by a
free lectin, does not necessarily mean that an immobilized derivative of
that lectin will bind and retain the receptor in question (Hedo, 1984). In
fact the lack of effect of a lectin on receptor binding does not mean that it
cannot be used in affinity chromatography, since there are examples of
purification o f the insulin receptor with ricin-agarose, even though free
ricin does not alter insulin binding (Hedo et al., 1981). WGA and Con A
have been used extensively in purification of a variety of receptors (Hedo,
1984), and, since both lectins interfere with IL-1 binding, it is quite
possible that immobilized-WGA or Con A would retain the IL-1 receptor.
Data presented here further suggest that specific simple sugars could be
used to elute bound IL-1 receptor from affinity columns.
The results observed fo llo w in g incubation o f YT cells w ith
tunicamycin, an antibiotic inhibitor of glycosylation, suggest that the IL-1
receptor may be glycosylated and that glycosylation is im portant for
ligand binding. Alternatively, tunicamycin treatment may have effected
IL-1 receptor expression levels by having a detrimental effect on proteins
involved mechanistically in receptor synthesis, transport, membrane
localization, function and/or membrane turnover. Tunicamycin has been
shown to selectively block glycoprotein synthesis by inhibition of NAGIu
derivatives, w ith o u t significant effect on overall protein synthesis
(Chatterjee etal., 1979; Rosen, Chia, Fung & Rubin, 1979). I observed that

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

37

during a 24 hour incubation with 5 ug/ml tunicamycin, cell viability was
unchanged. However, the ability of YT cells to bind WGA-FITC was only
somewhat decreased when these cells were tunicam ycin-treated,
suggesting only a partial inhibition o f glycosylation or slow turnover of
lectin binding sites. Tunicamycin's effect on IL-1 receptor binding was
related to both time and concentration, and was reversible upon removal
of tunicamycin from the culture medium. Restoration of ligand binding
following removal o f tunicamycin was a slow process, suggesting th a t
receptor turnover may not be rapid. Recently, Mizel, Dayer, Krane and
Mergenhagen (1981) reported a turnover rate of approximately 11 hours
for IL-1 receptors on murine EL4T cell lymphoma cells.
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CONCLUSION

I have demonstrated specific IL-1 receptors on human YT cells by
using iodinated IL-10 o f high specific activity in a rapid, intact cell binding
protocol. IL-1 binding was antagonized by the plant lectins WGA and Con
A in a concentration-dependent manner.

This in h ib itio n could be

completely abolished if WGA and Con A had been pre-incubated with the
lectin-specific sugars, NAGIu or MG. Incubation with tunicamycin, the
antibiotic inhibitor o f glycosylation, caused a reversible, tim e- and
concentration-dependent decrease in IL-1 binding.
These data suggest that glycoconjugate moieties on or near the IL-1
receptor site are important for optimal receptor binding in intact YT cells.
In addition, isolation and purification o f IL-1 receptors may be realized
through the use of immobilized-WGA or Con A deriviatives by affinity
chromatographic methods.
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